BOEHRINGER INGELHEIM PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at BOEHRINGER INGELHEIM PHARMACEUTICALS is $127,420, based on 294 certified filings from FY 2020 to FY 2026. This is 6% higher than the national H-1B median salary of $120,000. Compensation at BOEHRINGER INGELHEIM PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $108,829 and senior positions reaching $183,475 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at BOEHRINGER INGELHEIM PHARMACEUTICALS range from $80,000 at the 10th percentile to $183,475 at the 90th percentile, showing a $103,475 spread across experience levels and roles. The 25th percentile is $108,829 and the 75th percentile is $151,621.

Yes, BOEHRINGER INGELHEIM PHARMACEUTICALS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 296 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 294 certified applications and a 0% denial rate, BOEHRINGER INGELHEIM PHARMACEUTICALS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), BOEHRINGER INGELHEIM PHARMACEUTICALS filed 2 H-1B applications, with 2 certified and 0 denied. Over 7 years of data, BOEHRINGER INGELHEIM PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

BOEHRINGER INGELHEIM PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 296 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating BOEHRINGER INGELHEIM PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating BOEHRINGER INGELHEIM PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

BOEHRINGER INGELHEIM PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 294 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles BOEHRINGER INGELHEIM PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at BOEHRINGER INGELHEIM PHARMACEUTICALS:

The most frequently sponsored role is Senior Research Scientist with 60 filings at a median salary of $120,000. This is followed by Senior Data Scientist (25 filings) and Research Scientist II.

BOEHRINGER INGELHEIM PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where BOEHRINGER INGELHEIM PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top BOEHRINGER INGELHEIM PHARMACEUTICALS H-1B locations:

The largest H-1B hub for BOEHRINGER INGELHEIM PHARMACEUTICALS is Ridgefield, CT with 255 filings at a median salary of $128,520. The highest-paying location is Fremont, CA at $277,843 median. Salaries range from $112,571 to $277,843 across office locations.

BOEHRINGER INGELHEIM PHARMACEUTICALS's median H-1B salary has increased by +62% from FY 2020 ($114,000) to FY 2026 ($185,000). Tracking salary trends over time reveals how BOEHRINGER INGELHEIM PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at BOEHRINGER INGELHEIM PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $124,964 (58 certified)
• FY 2023: $127,472 (39 certified)
• FY 2024: $130,889 (42 certified)
• FY 2025: $150,000 (45 certified)
• FY 2026: $185,000 (2 certified)

This 62% growth reflects strong compensation adjustments at BOEHRINGER INGELHEIM PHARMACEUTICALS, keeping pace with market demands for H-1B talent.

BOEHRINGER INGELHEIM PHARMACEUTICALS primarily files H-1B applications at Wage Level II, accounting for 35% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making BOEHRINGER INGELHEIM PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 87% of positions at Level II or higher, BOEHRINGER INGELHEIM PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

BOEHRINGER INGELHEIM PHARMACEUTICALS's median H-1B salary of $127,420 is 6% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating BOEHRINGER INGELHEIM PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare BOEHRINGER INGELHEIM PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

BOEHRINGER INGELHEIM PHARMACEUTICALS offers above-average H-1B compensation. Combined with their 294 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. BOEHRINGER INGELHEIM PHARMACEUTICALS's higher proportion of Level III-IV positions (53%) may benefit from wage-based lottery prioritization.

With 294 certified filings, BOEHRINGER INGELHEIM PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.